PortViewPortView
Novan logo

Novan (NOVN) Stock Analysis

NASDAQHealthcareBiotechnology

$0.09-24.84%
1-year price historyRange $0.05 – $3.03
52-week range$0.09
$0.08$3.33

What Novan does

Novan, Inc. operates as a pre-commercial pharmaceutical entity specializing in nitric oxide-derived therapies for dermatological and anti-infective conditions. The company boasts a robust clinical-stage pipeline featuring several topical drug candidates. For skin-related ailments, these include SB204, a monotherapy aimed at acne vulgaris; SB206, an antiviral gel targeting viral skin infections; SB208, a broad-spectrum antifungal gel designed to combat various fungal skin and nail infections like athlete's foot; and SB414, a cream-based gel formulated for inflammatory skin diseases. Additionally, Novan is advancing SB207 to treat external genital warts, WH602 (an intravaginal gel) and WH504 (a non-gel formulation) both addressing high-risk human papillomavirus (HPV), and SB019, a candidate for SARS-CoV-2. The firm has cultivated strategic partnerships, holding a licensing agreement with Sato Pharmaceutical Co., Ltd., and engaging in a strategic alliance with Orion Corporation. Founded in 2006, Novan, Inc. maintains its headquarters in Durham, North Carolina.

Key metrics

Market cap
$2.64M
P/E (TTM)
-0.11
EPS (TTM)
$-0.84
Beta
-0.04
Dividend yield
0.00%
Revenue / share
$1.07
50-day avg
$0.75
200-day avg
$1.14
52-week high
$3.33
52-week low
$0.08
CEO
Paula Brown Stafford

ETFs linked to NOVN

Broad-market and Healthcare sector ETFs an investor holding Novan is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how NOVN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze NOVN in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Novan?
Novan trades under the ticker NOVN on NASDAQ.
Which exchange is NOVN listed on?
NOVN is listed on NASDAQ.
What sector does Novan operate in?
Novan is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze NOVN in a portfolio?
PortView shows NOVN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.